title: DNA repair enzyme expression and differential response to temozolomide in a patient with both glioblastoma and metastatic pancreatic neuroendocrine tumor.
authors.affiliation: Center for Neuro-Oncology, Boston, MA, USA.
authors.forename: Lynn-Kristin
authors.initials: LK
authors.lastname: Bracht
authors.forename: Patrick
authors.initials: P
authors.lastname: Wen
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Meyerhardt
authors.forename: Matthew H
authors.initials: MH
authors.lastname: Kulke
authors.forename: Jason L
authors.initials: JL
authors.lastname: Hornick
authors.forename: Mark
authors.initials: M
authors.lastname: Redston
authors.forename: Debra Conrad
authors.initials: DC
authors.lastname: LaFrankie
authors.forename: Peter M
authors.initials: PM
authors.lastname: Black
authors.forename: Santosh
authors.initials: S
authors.lastname: Kesari
authors.forename: Andrew
authors.initials: A
authors.lastname: Norden
authors.forename: Jan
authors.initials: J
authors.lastname: Drappatz
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000378:metabolism / Q000628:therapy*; D003131:Combined Modality Therapy; D045643:DNA Repair Enzymes / Q000096:biosynthesis*; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018450:Disease Progression; D017809:Fatal Outcome; D005909:Glioblastoma / Q000150:complications / Q000378:metabolism / Q000628:therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D008875:Middle Aged; D018358:Neuroendocrine Tumors / Q000150:complications / Q000188:drug therapy*; D010190:Pancreatic Neoplasms / Q000150:complications / Q000188:drug therapy*; D012074:Remission Induction; D000077204:Temozolomide
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D045643:DNA Repair Enzymes; D000077204:Temozolomide